Skip to main content

and
  1. Article

    Identification of time point to best define ‘sub-optimal response’ following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data

    To determine the average time-point at which it is best to define ‘sub-optimal response’ after ranibizumab treatment for diabetic macular edema (DME) based on the data obtained from real-life clinical practice.

    I Chatziralli, M Santarelli, N Patrao, L Nicholson, M Zola, R Rajendram, P Hykin in Eye (2017)

  2. Article

    Influence of baseline diabetic retinopathy status on initial anatomical response of intravitreal ranibizumab therapy for diabetic macular oedema

    Intraocular vascular endothelial growth factor (VEGF) levels increases with the severity of diabetic retinopathy. Response of diabetic macular oedema (DMO) to ranibizumab is driven by VEGF suppression. We hypo...

    L Nicholson, N V Patrao, J Ramu, C Vazquez-Alfageme, M Muwas, R Rajendram, P G Hykin in Eye (2017)

  3. Article

    Response to ‘Comment on Topiramate maculopathy secondary to dose titration: first reported case’

    R J Symes, P S Severn, R Rajendram, B Pal in Eye (2016)

  4. Article

    Topiramate maculopathy secondary to dose titration: first reported case

    P S Severn, R Symes, R Rajendram, B Pal in Eye (2015)

  5. Article

    Using data from the Cataract National Dataset electronic multicentre audit to calculate risk of posterior capsule rupture and vitreous loss for patients on current surgical lists

    P K F Addison, R Rajendram, H Bradshaw, P G Hykin in Eye (2011)

  6. Article

    Intravitreal ranibizumab for choroidal neovascularisation secondary to pathologic myopia: 12 month results

    R Rajendram, N Costa-Gomes, S E Horgan in Eye (2010)

  7. Article

    Realignment of a previously dislocated intraocular lens with a secondary intraocular lens: a rare cause of severe myopia

    S Dhesi, R Rajendram, A Elliott in Eye (2010)

  8. Article

    Keratoconus in tuberous sclerosis

    R Wong, R Rajendram, T R G Poole in Eye (2007)

  9. Article

    Eclipse retinopathy

    Purpose Solar retinopathy is a well-recognised clinical entity of macular damage caused by viewing the sun, induced by a photochemical process. The term ‘eclipse retinopathy’ is frequently employed when the condi...

    M Michaelides, R Rajendram, J Marshall, S Keightley in Eye (2001)